Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sako M is active.

Publication


Featured researches published by Sako M.


Journal of Thoracic Imaging | 1993

Interstitial lung disease in rheumatoid arthritis: assessment with high-resolution computed tomography.

Masahiko Fujii; Shuji Adachi; Tadafumi Shimizu; Shozo Hirota; Sako M; Michio Kono

Interstitial lung disease (ILD) is a frequent manifestation of rheumatoid arthritis (RA), and it has a close bearing on the prognosis of RA patients. Computed tomography (CT) has been shown to be excellent for the diagnosis of diffuse lung disease. In this study chest radiographs and high-resolution CT (HRCT) scans were obtained in 91 patients with RA to evaluate their ILD precisely. By HRCT 43 patients could be diagnosed as having interstitial pneumonitis (IP), and 5 could be diagnosed as having bronchiolitis. The remaining 43 patients were normal by HRCT. Chest radiographic findings were consistent with the HRCT findings in approximately 50% of patients with IP. HRCT was superior to chest radiographs for the detection of early interstitial changes. The histogram of HRCT values might be a useful adjunct to HRCT diagnosis by adding some degree of objectivity. HRCT is useful for the diagnosis of ILD in patients with RA.


Annals of Surgery | 1998

Induction of long-term remission in advanced hepatocellular carcinoma with percutaneous isolated liver chemoperfusion.

Y. Ku; Takeshi Iwasaki; Takumi Fukumoto; Masahiro Tominaga; Sanshiro Muramatsu; Nobuya Kusunoki; Takemi Sugimoto; Y. Suzuki; Y. Kuroda; Yoichi Saitoh; Sako M; Shinichi Matsumoto; Shodo Hirota; Hidefumi Obara

OBJECTIVE The aim of this study was to report the long-term results of percutaneous isolated liver chemoperfusion with hepatic venous isolation and charcoal hemoperfusion (HVI-CHP) in patients with multiple advanced hepatocellular carcinoma (HCC). SUMMARY BACKGROUND DATA The results of conventional chemotherapy including regional and systemic chemotherapy in patients with HCC remain dismal, and long-term survivors after treatment are rare among patients with multiple advanced HCC. In an effort to improve this situation, we previously developed a novel system of percutaneous isolated liver chemoperfusion with HVI-CHP. METHODS Doxorubicin (60 to 150 mg/m2) was administered via the hepatic artery, under conditions of extracorporeal drug elimination by HVI-CHP in 28 consecutive patients with advanced HCC (39 total treatments). Hepatic venous isolation and charcoal hemoperfusion was accomplished mainly by the single catheter technique using a newly developed 4-lumen-balloon catheter, which was used to isolate and capture total hepatic venous outflow and, at the same time, to direct the filtered blood to the right atrium. RESULTS Complete remission was achieved in five patients, of which four received repeated treatments (two or three times). Although 1 of 5 patients with complete remission died of pulmonary metastases at 8 months, the other 4 remain healthy and free of disease at 20, 24, 27, and 42 months after the first treatment. Partial responses were observed in 12 patients. Duration of response in responders (complete and partial) with repeated treatments was significantly longer than that with a single treatment (p = 0.01). The overall survival rate by the Kaplan-Meier method was 39.7% at 5 years. The treatments were well-tolerated, and the primary side effects were mild to moderate chemical hepatitis and reversible myelosuppression. CONCLUSIONS The results suggest that percutaneous isolated liver chemoperfusion with HVI-CHP is an effective palliative treatment in the majority of patients and yields long-term complete remission in some patients with multiple advanced HCC.


Surgery | 1995

Clinical pilot study on high-dose intraarterial chemotherapy with direct hemoperfusion under hepatic venous isolation in patients with advanced hepatocellular carcinoma

Yonson Ku; Takumi Fukumoto; Takeshi Iwasaki; Masahiro Tominaga; Masahiro Samizo; Tokihito Nishida; Yoshikazu Kuroda; Shozo Hirota; Sako M; Hidefumi Obara; Yoichi Saitoh

BACKGROUND We recently developed a novel system of direct hemoperfusion under hepatic venous isolation in an attempt to achieve high-dose intraarterial chemotherapy for patients with malignant liver tumors. We report here the results of treatment of these patients with advanced hepatocellular carcinoma. METHODS Adriamycin (100 to 150 mg/m2) was administered into the hepatic artery of 15 patients, under conditions of extracorporeal drug elimination by direct hemoperfusion under hepatic venous isolation. Hepatic venous isolation was accomplished mainly by the double-balloon technique with an occlusion catheter and a balloon catheter. The isolated hepatic venous blood was filtered by direct hemoperfusion and pumped to the left axillary vein. RESULTS During 5 minutes of adriamycin infusion, the mean drug extraction ratios of the direct hemoperfusion filters were 91% +/- 9% (mean +/- SD). The amount of drug removed by the system was 26.4% +/- 16.0% of the amount of drug administered. Two patients died, one of necrotizing pancreatitis and the other of hepatic arterial thrombosis. Both deaths were related directly to the hepatic arterial catheter. Other side effects included hemolysis related to the system of hemoperfusion (87%), chemical hepatitis (80%), leukopenia less than 3000/mm3 (67%), alopecia (33%), and nausea and vomiting (20%). Nine (64%) of 14 evaluable patients had objective tumor responses, with a median duration of response of 6.2 months. CONCLUSIONS This approach offers an effective therapeutic option for patients with advanced hepatocellular carcinoma.


American Journal of Surgery | 1997

Single catheter technique of hepatic venous isolation and extracorporeal charcoal hemoperfusion for malignant liver tumors.

Y. Ku; Takumi Fukumoto; Masahiro Tominaga; Takeshi Iwasaki; Ichiro Maeda; Nobuya Kusunoki; Hidefumi Obara; Sako M; Y. Suzuki; Y. Kuroda; Yoichi Saitoh

BACKGROUND A single catheter technique of hepatic venous isolation and charcoal hemoperfusion (HVI-CHP) using a 4-lumen/2-balloon (4L-2B) catheter was developed to perform high-dose intra-arterial chemotherapy of the liver. Herein we report the technique, safety, and pharmacokinetics of this system in comparison with the original double-balloon technique. PATIENTS AND METHODS Sixteen patients with malignant liver tumors were treated by hepatic arterial infusion (HAI) with adriamycin at a dose of 100 mg/m2 under HVI-CHP. Seven patients underwent HVI-CHP by the double-balloon technique (group A), in which filtered hepatic effluent and the rest of the inferior vena caval blood were separately drawn and returned to the left axillary vein. The other nine patients were treated by the single catheter technique (group B). In group B, hepatic effluent was isolated by balloon inflations and directed to filters through fenestrations of one major lumen of a 4L-2B catheter. The filtered blood was returned straight to the right atrium through the other major lumen of the catheter. RESULTS All patients in group A had a smooth stepwise induction of HVI-CHP, whereas one of nine patients in group B developed severe hypotension requiring interruption of HVI. The hepatic venous flow rate in group B during HVI-CHP was significantly higher than that in group A (P < 0.05). Systemic adriamycin exposure, as assessed by the area under the time concentration curve in systemic serum, was significantly higher in group A compared to that in group B (P < 0.01). CONCLUSIONS The single catheter technique is hemodynamically tolerable and feasible in the majority of patients with malignant liver tumors. In view of systemic drug exposure, the single catheter technique is superior to the original double-balloon technique.


CardioVascular and Interventional Radiology | 1997

Simultaneous Thrombolysis of Superior Mesenteric Artery and Bilateral Renal Artery Thromboembolisms with Three Transfemoral Catheters

Shozo Hirota; Shinichi Matsumoto; Takeshi Yoshikawa; Satoshi Ichikawa; Sako M; Michio Kono

Abstract Successful treatment was achieved for a patient with superior mesenteric artery thromboembolism concomitant with bilateral renal artery thromboembolism. Thrombi of the three vessels were lysed simultaneously with a three-catheter technique using short-term, high-dose urokinase followed by overnight infusion with low-dose urokinase.


CardioVascular and Interventional Radiology | 1997

Suprarenal inferior vena cava filter placement prior to transcatheter arterial embolization (TAE) of a renal cell carcinoma with large renal vein tumor thrombus: Prevention of pulmonary tumor emboli after TAE

Shozo Hirota; Shinnichi Matsumoto; Satoshi Ichikawa; Masaru Tomita; Tukasa Koshino; Sako M; Michio Kono

To prevent embolization of necrotic renal vein tumor after transcatheter embolization of a left renal cell carcinoma, we placed a suprarenal Bird’s nest inferior vena cava filter. The patient tolerated the procedure well and had extensive tumor infarction including the tumor thrombus on 6-month follow-up computed tomography.


Investigative Radiology | 1982

Transcatheter microembolization with ferropolysaccharide. A new approach to ferromagnetic embolization of tumors: preliminary report.

Sako M; Shusaku Yokogawa; Kazuo Sakomoto; Shuji Adachi; Shozo Hirota; Satoshi Okada; Shin-Ichi Murao

A new embolic material has been devised to improve the therapeutic effect of ferromagnetic embolization upon tumors. Iron sponge microspheres (diameter 10-30 mu) were suspended in viscous, aqueous polysaccharide solution, dextran 40, and sodium carboxymethyl cellulose (Ferro-polysaccharide, FPS). Transcatheter embolization with FPS was performed under external magnetic control (2,800 gauss) in dog kidneys and VX2 carcinomas of rabbits, causing widespread, intraparenchymal vascular occlusion of target vessels. Neither recanalization nor collateral circulation was found to the infarcted areas, and the embolized tumors had extensive necrosis with resultant tumor regression. No significant untoward reaction or other undesirable embolization was noted serologically or histologically, even after intravenous administration of FPS. Clinical application to two patients, one with a hepatoma and the other with a renal cell carcinoma, resulted in excellent tumor infarction with no significant side effects.


International Journal of Radiation Oncology Biology Physics | 1991

Histopathological study of the esophageal injury induced by high-dose-rate intracavitary irradiation

Toshinori Soejima; Takeyuki Kushima; Akihisa Kodama; Toshiya Sakaguchi; Kazuyuki Yonezawa; Takahisa Hashimura; Kazufumi Imanaka; Sako M; Michio Kono

The histopathological responses of the rabbit esophagus to high-dose-rate intracavitary irradiation were investigated. After 5, 10 or 15 Gy irradiation using a remote afterloading system, the rabbits were sacrificed on different occasions. The esophagus was excised from each animal and examined histopathologically. Esophageal ulcer was observed 7 to 28 days after the irradiation of the highest dose. Edema and cell infiltration in the lamina propria proceeded mucosal changes like ulcer. Chronic injuries such as mucosal necrosis were seen at 6 months.


Haigan | 1986

Experimental study on bronchial arterial infusion therapy with polysaccharide solution as a carrier of anticancer drugs.

Masakazu Hasegawa; Sako M; Shuji Adachi; Shozo Hirota; Shuhei Ohtsuki; Tadafumi Shimizu; Hideaki Watanabe; Katsuro Hanaguri; Michio Kono

気管支動脈内制癌剤注入療法における効果増強の試みとして, 粘稠な多糖類 (PS) をcarrierとした制癌剤の動注療法を考案し, 動物実験において本剤の局所滞留性及び徐放性が確認された. 組織学的検索では, 腫瘍組織と同時に所属リンパ節内にPSが滞留していたが, 正常組織への障害はみられず, 安全で優れた治療効果が期待される.


Haigan | 1979

Studies of Bronchial Arteriograms in Lung Cancer Correlation between Patterns of Tumor Stain and Histologic Types

Sako M; Michio Kono; Sakamoto K; Shusaku Yokogawa; Shuji Adachi

肺癌における気管支動脈造影に, 拡大撮影及びsubtractionを併用し, 造影像と組織型の関連につき検討した.その結果, 遅い動脈相でみられる小点状影の数や気管支一肺血管吻合は, 組織型により異った態度を示した.特に, 腫瘍濃染像は組織型により, 異った特徴あるpatternを示した.これは, 個々の腫瘍における微細な血管構築が集約されたものと考えられ, patternの分析は, 肺癌の治療効果や予後の判定に有意義である.

Collaboration


Dive into the Sako M's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge